In Situ Simulation Training in Transferring Critically Ill COVID-19 Patients
In Situ Simulation Training for a Better Interprofessional Team Performance in Transferring Critically Ill COVID-19 Patients: A Prospective Randomized Control Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aimed to determine the role of in situ simulation training during a pandemic by using standard and high-fidelity mannequins to improve interprofessional communication, skills, and teamwork in transferring critically ill COVID-19 patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2021
CompletedFirst Submitted
Initial submission to the registry
October 25, 2021
CompletedFirst Posted
Study publicly available on registry
November 9, 2021
CompletedNovember 9, 2021
November 1, 2021
3 days
October 25, 2021
November 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
rate of interprofessional communication
improvement of interprofessional communication in transferring critically ill COVID-19 patients
within 3 months
rate of skill
improvement of skill in transferring critically ill COVID-19 patients
within 3 months
rate of team work
improvement of team work in transferring critically ill COVID-19 patients
within 3 months
Study Arms (2)
High Fidelity Simulator
ACTIVE COMPARATORSubjects will receive training using high fidelity simulator
Low Fidelity Simulator
ACTIVE COMPARATORSubjects will receive training using low fidelity simulator
Interventions
Simulation Training using High and Low Fidelity Simulator
Eligibility Criteria
You may qualify if:
- in good physical condition
- had no history of involving in COVID-19 patients care
- willing to become study subject
You may not qualify if:
- doesn't want to become study subject
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cipto Mangunkusumo Cental National Hospital
Jakarta, DKI Jakarta, 10430, Indonesia
Related Publications (1)
Manggala SK, Tantri AR, Sugiarto A, Sianipar IR, Prasetyono TOH. In situ simulation training for a better interprofessional team performance in transferring critically ill patients with COVID-19: a prospective randomised control trial. Postgrad Med J. 2022 Aug;98(1162):617-621. doi: 10.1136/postgradmedj-2021-141426. Epub 2022 Jan 31.
PMID: 35101969DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
October 25, 2021
First Posted
November 9, 2021
Study Start
November 16, 2020
Primary Completion
November 19, 2020
Study Completion
March 15, 2021
Last Updated
November 9, 2021
Record last verified: 2021-11